Connect with us

Health

The year in cancer: Advances made in 2024, predictions for 2025

Published

on

The year in cancer: Advances made in 2024, predictions for 2025

Join Fox News for access to this content

Plus special access to select articles and other premium content with your account – free of charge.

By entering your email and pushing continue, you are agreeing to Fox News’ Terms of Use and Privacy Policy, which includes our Notice of Financial Incentive.

Please enter a valid email address.

Having trouble? Click here.

At the beginning of 2024, the American Cancer Society predicted that 2,001,140 new cancer cases and 611,720 cancer deaths would occur in the United States.

Now, as the year draws to a close, experts are looking back and reflecting on the discoveries and advances that have been made in the field of cancer treatment and prevention.

Advertisement

Fox News Digital spoke with four oncologists from the Sarah Cannon Research Institute in Nashville, Tennessee, about the most notable accomplishments of 2024 and what they see on the horizon for 2025. 

5 CANCER TYPES WHERE SCREENINGS SAVE THE MOST LIVES

See the answers and questions below. 

Krish Patel, MD, director of lymphoma research

Krish Patel, M.D., is director of lymphoma research at Sarah Cannon Research Institute in Nashville, Tennessee. (Sarah Cannon Research Institute )

Q: What do you see as the most important cancer advances in 2024?

A: In the field of lymphomas, we see growing momentum for therapies that use the patient’s own immune system to fight their cancer, such as CAR T-cell therapy and bispecific antibodies. 

Advertisement

These are treatments that are now being studied and are making an impact earlier in the disease course, including one now being studied as the very first treatment a patient might receive for their lymphoma. 

PANCREATIC CANCER PATIENT SURVIVAL DOUBLED WITH HIGH DOSE OF COMMON VITAMIN, STUDY FINDS

These treatments are helping us to be less dependent on chemotherapies (which may be effective but have broad side effects) for the treatment of lymphomas.  

Q: What are your predictions for cancer research in 2025?

A: Every year we are improving the curative treatment options we have for specific types of lymphomas, such as diffuse large B-cell lymphoma (DLBCL), which is the most common lymphoma we see. 

We are also gradually becoming better able to offer these treatments closer to – or in – patients’ homes and communities, so they can receive the best care as close to home as possible. 

Advertisement

“Every year, we are improving the curative treatment options we have for specific types of lymphomas.”

I believe that in 2025, we will continue to see more advancement in immunotherapies, development of more targeted therapies (including oral medicines), and hopefully soon the approval of next generations of immunotherapies that may work for patients who have already received today’s immunotherapies but need more treatment options.

Q: How has the state of cancer in your specialty area changed and evolved over the past decade?

A: It has changed and evolved dramatically. A decade ago, care for lymphomas was primarily chemotherapy-based. Now, we are shifting rapidly away from chemotherapies in some types of lymphomas in favor of immunotherapies and targeted oral therapies that lead to excellent long-term outcomes for patients, with fewer side effects than historical treatments.

As 2024 comes to an end, experts are looking back and reflecting on the discoveries and advances that have been made in the field of cancer treatment and prevention. (iStock)

Q: What can people do to reduce their cancer risk?

A: We think of lymphomas as diseases of aging for most patients. Some patients may have select risk factors, such as being on specific immunosuppressants or having exposure to very specific industrial chemicals. 

Advertisement

Those risks may or may not be so modifiable for patients, and they represent the minority of patients who develop lymphoma. 

AI DETECTS WOMAN’S BREAST CANCER AFTER ROUTINE SCREENING MISSED IT: ‘DEEPLY GRATEFUL’

While it is not entirely clear what modifiable risks patients may have, there is ongoing work to help better answer that question. However, we know that the better general health someone is in, the more likely they are to have any and all treatment options available to them. 

I would say that for most people, exercising regularly, eating well and sleeping regularly are important.

Q: Anything else people should know?

A: There is great hope and a lot of exciting science happening to help us drive toward more cures, more effective treatments and less toxic treatments for lymphomas. 

Advertisement

We have already made major strides in the last decade, and we continue to build on that momentum through clinical trials that provide early access to cutting-edge therapies. 

Exercising regularly, eating well and getting enough sleep are all recommended activities to help prevent cancer risk, experts agreed. (iStock)

For patients, participating in clinical trials may help to close that time gap between the treatments that are broadly available today and the treatments we expect to be available years from now. 

They also provide a way for patients to contribute positively to the care patients in future generations may receive, which I have been told by many of my patients is something they really want to do and something that is important to them.

Erika Hamilton, MD, director of breast cancer research

Erika Hamilton, M.D., is director of breast cancer research at Sarah Cannon Research Institute in Nashville, Tennessee. (Sarah Cannon Research Institute)

Advertisement

Q: What do you see as the most important cancer advances in 2024?

A: The two most exciting focuses of 2024 were 1) expansion of targeted therapies in the curative setting for hormonally driven breast cancer and 2) antibody drug conjugates. 

First, three different CDK4/6 inhibitors have been approved in the metastatic setting, and they improve survival and outcomes. 

Treatments that are precisely tailored to the genetic makeup of a person’s cancer are becoming more widely available, experts say. (iStock)

In 2024, we saw the approval of a second one in the curative setting, enabling us to identify the highest-risk patients and offer them something additional to endocrine therapy to improve cure rates.

Second, we now have multiple antibody drug conjugates approved across all types of breast cancer. These therapies target a chemotherapy drug directly to the tumor via an antibody-honing mechanism and largely spare normal body cells.

Advertisement

“I anticipate drugs that are better tolerated with decreased side effects for patients, and a continued emphasis on personalized medicine.”

Q: What are your predictions for cancer advances in 2025?

A: I anticipate seeing more targeted agents in 2025 and the approval of antibody drug conjugates in curative early breast cancer — currently, most are only approved in metastatic cancer.

[I also anticipate] drugs that are better tolerated with decreased side effects for patients, and a continued emphasis on personalized medicine. 

Q: How has the state of cancer in your specialty area changed and evolved over the past decade? 

A: In 2024, truly personalized medicine is possible, from mutation testing to direct targeted therapy to what a cancer needs to grow — as well as being able to provide many HR+ breast cancer patients with curative chemotherapy through personalized risk stratification assays.

“I anticipate seeing more targeted agents in 2025 and the approval of antibody drug conjugates in curative early breast cancer,” said Hamilton (not pictured). (iStock)

Advertisement

Q: What can people do to reduce their cancer risk?

A: Continued breast screening with mammograms yearly is really important to find cancers earlier when a cure is more likely.  

People can also reduce their risk through avoiding alcohol and cigarettes and making sure they get regular exercise and maintain a normal body weight.

Vivek Subbiah, MD, chief of early-phase drug development

Vivek Subbiah, M.D., is chief of early-phase drug development at Sarah Cannon Research Institute in Nashville, Tennessee. (Sarah Cannon Research Institute )

Q: What do you see as the most important cancer advances in 2024?

A: In 2024, precision cancer treatment made big strides with many new drug approvals by the FDA, specifically for treatments guided by specific biomarkers, which means treatments can be more precisely tailored to the genetic makeup of a person’s cancer. 

BREAST CANCER VACCINE UPDATE FROM CLEVELAND CLINIC: ‘A NEW ERA’

Advertisement

A key change was moving some therapies from faster, temporary approval processes to full approval, showing strong evidence that these targeted therapy drugs, such as tepotinib and amivantamab for certain types of lung cancer, are effective and safe. 

There were also new drug approvals for rare cancers, including tovorafenib, a BRAF precision medicine for a rare type of brain tumor in children, and afamitresgene autoleucel, a type of immunotherapy for a rare cancer called synovial sarcoma. This highlights important progress in treating these challenging conditions.

“In 2024, precision cancer treatment made big strides with many new drug approvals by the FDA, specifically for treatments guided by specific biomarkers,” Subbiah (not pictured) told Fox News Digital. (iStock)

We have also seen the approval of precision therapies that work on different types of cancer — not just one specific cancer. This is what we call “tissue-agnostic therapies.” 

One such drug is an antibody drug conjugate called trastuzumab deruxtecan, which acts like a smart missile targeting HER2-positive cancers. Another is repotrectinib, which works on any cancer that has the NTRK biomarker, regardless of where it is in the body.

Advertisement

Q: What are your predictions for cancer advances in 2025?

A: By 2025, cancer research is likely to see advancements in precision oncology and the use of artificial intelligence. 

In precision oncology, we can expect more personalized treatment plans based on an individual’s genetic makeup, leading to more effective and targeted therapies with fewer side effects. 

      

Additionally, AI will likely play a larger role in analyzing vast amounts of data to identify new drug targets, predict patient responses to treatments and enhance early detection methods. 

These advancements have the potential to improve cancer diagnosis, treatment and overall patient outcomes.

Advertisement

Q: How has the state of cancer in your specialty area changed and evolved over the past decade? 

A: In the last 10 years, cancer treatment has changed dramatically. By using genetic information to create personalized treatments that match the specific details of each person’s cancer, therapies are more effective and less harmful. 

“In precision oncology, we can expect more personalized treatment plans based on an individual’s genetic makeup,” Subbiah said. (iStock)

New technologies such as analyzing cancer’s genetic profile, blood tests that detect cancer, and treatments that boost the immune system have greatly improved how we diagnose, track and treat cancer, leading to better results for patients.

Q: What can people do to reduce their cancer risk?

A: To lower the risk of cancer, people can avoid smoking, eat a healthy diet, exercise regularly, limit alcohol, protect their skin from the sun and maintain a healthy weight.

Q: Anything else people should know?

A: Get vaccines for viruses like HPV and hepatitis B, as they can lead to some cancers. Also, go for regular health checks to catch any signs of cancer early. 

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

We are in a unique time when treatments can be tailored specifically to each person, and many of these are available through clinical trials. If you or a loved one is diagnosed with cancer, ask your doctor if there are any clinical trials that might be a good fit.

Meredith McKean, MD, MPH, director of melanoma and skin cancer research

Meredith McKean, M.D., MPH, is the director of melanoma and skin cancer research at Sarah Cannon Research Institute in Nashville, Tennessee. (Sarah Cannon Research Institute)

Q: What do you see as the most important cancer advances in 2024?

A: The first cellular therapy, Lifileucel, was approved in melanoma after decades of research in academia and industry. 

“We are in a unique time when treatments can be tailored specifically to each person, and many of these are available through clinical trials.”

Advertisement

This is a significant step forward for both patients with melanoma, but also the field of oncology at large.

Q: What are your predictions for cancer advances in 2025?

A: As we look to bring effective therapies from the metastatic setting into early stages of disease, we are anxiously awaiting updates in the next 18 to 24 months for a number of ongoing trials for combination therapy for patients with high-risk stage 2 or 3 melanoma.

In 2024, the first cellular therapy, Lifileucel, was approved in melanoma after decades of research, according to Meredith McKean, M.D., of the Sarah Cannon Research Institute (not pictured). (iStock)

Q: How has the state of cancer in your specialty area changed and evolved over the past decade? 

A: Outcomes for melanoma have significantly changed over the past 10 years. 

For more Health articles, visit www.foxnews.com/health

Advertisement

The five-year survival for patients with a diagnosis of stage 4 melanoma was less than 5% before 2010, and now clinical trials have shown that more than 50% of patients are still alive 10 years after being treated with FDA-approved immune checkpoint inhibitors.

Q: What can people do to reduce their cancer risk?

A: Lifelong sun protective measures, such as wearing sunscreen, avoiding direct UV exposure during peak hours of 10 a.m. to 2 p.m., and avoiding tanning beds continue to be important starting at an early age.

Health

Dr Oz links obesity to chronic disease surge, says GLP-1s can ‘jumpstart’ better health

Published

on

Dr Oz links obesity to chronic disease surge, says GLP-1s can ‘jumpstart’ better health

NEWYou can now listen to Fox News articles!

GLP-1 weight-loss drugs have become a prevalent part of American healthcare, and the current administration is getting behind the movement.

In an exclusive interview with Fox News Digital at the Great American State Fair in the nation’s capital on July 6, CMS Administrator Dr. Mehmet Oz voiced his support for the use of GLP-1 (glucagon-like peptide-1) medications, such as Ozempic, for appropriate uses.

“I’m a fan of GLP-1 drugs when used correctly,” he said. “They do help people who are overweight lose weight quite effectively. They’re not a replacement for diet and exercise, but they might jumpstart the system so it’s easier for you to use healthier tactics.”

DR OZ WARNS MEDICARE SCAMMERS ARE STEALING BILLIONS — AND YOUR PERSONAL INFORMATION COULD BE NEXT

Advertisement

This is especially helpful for those who may have trouble moving due to joint pain or are experiencing internal dysfunction, Oz said.

Certain GLP-1 drugs are covered by Medicare for overweight candidates with certain conditions, such as high blood pressure and diabetes, and Oz projected the benefits will continue to benefit taxpayers.

Dr. Mehmet Oz is pictured in Washington, D.C., at the Great American State Fair, where he spoke about federal health policy. (Angelica Stabile/Fox News Digital)

“We believe these are so effective in reducing conditions like high blood pressure and diabetes that they’ll actually save money for the federal taxpayer, because [they’re] going to make you healthy enough that you don’t have to consume health services,” Oz said.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Advertisement

“We think about 70% of all the money we spend on healthcare is caused by chronic conditions, and obesity is the No. 1 driver of all that, so it’s a smart decision.”

Oz recently announced the launch of the Medicare GLP-1 Bridge program, which will allow more seniors to access GLP-1 drugs for only $50 a month if they meet qualifying health criteria and receive prior authorization from a doctor.

The doctor expressed support for broadening affordable access to GLP-1 medications for Americans. (iStock)

“There are a lot of overweight people who don’t have high blood pressure, diabetes or other conditions, so they don’t get access to the drug normally,” he said. “We want them to have the ability to use it as well.”

Although these access shifts could boost Americans’ overall health — and in some cases could be lifesaving — Oz noted that there is “no silver bullet” when it comes to these medications.

Advertisement

CLICK HERE FOR MORE HEALTH STORIES

“I love the fact that the innovation that’s coming out of pharmaceutical companies is allowing us to save lives and make lives better,” he said. “But the real secret to longevity is eating right, exercising, sleeping, dealing with the stress of your life, finding some purpose in your existence [and] realizing you have agency over the future.”

“These are things that your mom would have told you [and that] you don’t need a doctor to be emphasizing.”

Medicating appropriately, combined with eating right, exercising and staying connected with others, can help make health goals attainable, the doctor said. (iStock)

While GLP-1s may not be a fix-all, combining these medications with foundational health practices “makes a lot of sense,” Oz said.

Advertisement

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“I don’t want people being fat-shamed … I don’t want you feeling guilty that you’re gaining weight even though everyone else around you seems to have figured it out,” he said. “It’s not that simple — our set points for hunger are different. We have different things going on in our lives.”

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

“But if you realize how precious you are — the temple of the soul is so valuable. It’s the greatest gift your parents ever gave you, and you take advantage of every tool out there to make it work … which includes using medications when appropriate. That, to me, is MAHA.”

Advertisement
Continue Reading

Health

Deadly Legionnaires’ disease outbreak sparks concern in major US city: Know the symptoms

Published

on

Deadly Legionnaires’ disease outbreak sparks concern in major US city: Know the symptoms

NEWYou can now listen to Fox News articles!

Amid warnings of a Legionnaires’ disease outbreak on Manhattan’s Upper East Side, health experts say that early recognition of symptoms can mean the difference between a quick recovery and life-threatening complications, especially for high-risk groups.

New York City health officials are urging anyone who has visited the east side of Central Park or Manhattan’s Upper East Side since late June to watch for symptoms.

As of July 6, the New York City Health Department had confirmed 23 cases and 17 hospitalizations associated with the respiratory infection. No deaths have been reported.

NYC HEALTH OFFICIALS WARN OF LEGIONNAIRES’ DISEASE OUTBREAK IN CENTRAL PARK AREA

Advertisement

Officials are investigating contaminated cooling towers as the likely source. They have emphasized that the illness is not spread person-to-person and is not linked to the city’s drinking water.

Health experts say that early recognition of symptoms can mean the difference between a quick recovery and life-threatening complications, especially for high-risk groups. (iStock)

“Legionnaires’ disease is deadly but can be effectively treated if diagnosed early,” said NYC Health Commissioner Dr. Alister Martin in a press release. “New Yorkers at higher risk, including anyone who is 50 and older, those who smoke or people with chronic lung conditions should be especially mindful of their symptoms and seek care as soon as symptoms begin.”

What is Legionnaires’?

Legionnaires’ disease is a type of pneumonia caused by Legionella bacteria.

The bacteria is usually found in lakes, streams and other freshwater environments, but can grow in any area where water sits for a long time, according to the CDC.

Advertisement

RARE TICK-BORNE VIRUS TURNS DEADLY FAST AS US CASES REACH RECORD HIGH, EXPERTS WARN

That can include shower heads, sink faucets, hot tubs, water features/fountains, plumbing systems and other water systems.

When people swallow or breathe in droplets of water that contain Legionella, they can potentially become ill.

Although human transmission is possible in rare cases, the disease is not typically transmitted among people, per the Centers for Disease Control and Prevention.

Symptoms of infection

Infections can lead to severe pneumonia in older people and those with compromised immune systems, according to Dr. Andrew Handel, a pediatric infectious diseases expert at Stony Brook Children’s Hospital on Long Island, New York.

Advertisement

Symptoms of Legionnaires’ disease usually show up between two and 14 days after exposure.

New York City health officials are urging anyone who has visited the east side of Central Park or Manhattan’s Upper East Side since late June to watch for symptoms. (iStock)

“Legionella infections cause symptoms that are similar to other forms of pneumonia — fever, coughing, difficulty breathing, shortness of breath and chest pain,” Handel previously told Fox News Digital.

“Legionnaires’ disease is deadly but can be effectively treated if diagnosed early.”

The signs are similar to other types of pneumonia, and include the following:

Advertisement
  • Cough
  • Fever
  • Shortness of breath
  • Muscle aches and headaches

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Some patients may also experience nausea, diarrhea and confusion, the CDC noted.

Diagnosis, treatment and prevention

A medical professional can diagnose the infection with laboratory tests and chest X-rays.

The condition is typically treated with antibiotics. In cases of severe infection, hospitalization may be required for breathing support and IV hydration.

Around 10% of people who contract Legionnaires’ disease will die from those complications — and the mortality risk rises to 25% for those who get Legionnaires’ while staying in a healthcare facility, according to the CDC.

The bacteria is usually found in lakes, streams and other freshwater environments, but can grow in any area where water sits for a long time, according to the CDC. (iStock)

Advertisement

“Treatment needs to be early and aggressive,” Dr. Nathan Goodyear, an Arizona-based integrative medicine expert, previously told Fox News Digital. “Legionella infection is an intracellular infection that requires antibiotic treatment.”

Antibiotics that are appropriate for Legionella infection include Levofloxacin and Azithromycin. 

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“Therapy can be prescribed orally in healthy individuals… but intravenous antibiotics often prove to be the initial option for treatment secondary to the pathogenicity of the disease,” Goodyear said.

Currently, there are no vaccines for Legionnaires’ disease. 

Advertisement

CLICK HERE FOR MORE HEALTH STORIES

The best strategy to prevent infection is to reduce the growth and spread of the Legionella bacteria. The CDC recommends that building owners and managers use a water management program to reduce the risk.

“New Yorkers at higher risk, including anyone who is 50 and older, those who smoke or people with chronic lung conditions should be especially mindful of their symptoms and seek care as soon as symptoms begin,” city officials stated. (iStock)

To prevent serious illness from Legionnaires’, Goodyear recommends that all smokers kick the habit, and also emphasizes the need to “aggressively support” chronic pulmonary disease.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Advertisement

“Increasing immune support (vitamin D3, vitamin C, Zinc) is required to counter the immune dysfunction associated with advancing age.”

Obesity is another foundational risk factor for all chronic inflammatory diseases, the doctor added.

Advertisement
Continue Reading

Health

Katie Couric couldn’t remember the year or the president during frightening brain episode

Published

on

Katie Couric couldn’t remember the year or the president during frightening brain episode

NEWYou can now listen to Fox News articles!

Journalist Katie Couric is sharing a scary medical episode that she experienced on June 27.

In a post on Substack titled “The Day I’ll Never Remember,” she detailed a sudden episode that left her unable to recall the current month, year and president.

“I thought it was 2024. And I believed Joe Biden was president,” she wrote.

ONE WALKING HABIT COULD SIGNAL A HEALTHIER BRAIN AFTER 80, SCIENTISTS SAY

Advertisement

The event occurred while Couric was attending the Aspen Ideas Festival in Colorado, during which she participated in two public panels — one on AI and one on journalism — both of which she cannot remember at all.

“I have no idea what we talked about, or of what occurred when the panels ended,” she said.

Journalist Katie Couric is sharing a scary medical episode that she experienced on June 27. (Getty Images)

John Molner — Couric’s husband, who was in attendance at the festival and the two panels — also shared his account.

After the event, someone told Molner that Katie wasn’t feeling well. When he reached her, an EMT and a doctor were tending to her. “I could tell something was off,” he wrote. “It could have been altitude sickness, but Katie was definitely not all there.”

Advertisement

WOMAN WITH ADVANCED ALZHEIMER’S REGAINED SPEECH AND MEMORIES AFTER TAKING MAGIC MUSHROOMS

At the hospital, when Couric struggled to recall the year, the president and her grandchildren’s names, doctors began checking for a stroke.

An MRI revealed no signs of stroke, which was a relief, but “Katie’s ‘fog’ became a lot more apparent,” Molner wrote.

John Molner, Couric’s husband, who was in attendance at the festival and the two panels, also shared his account. (Getty Images)

“She repeatedly asked me the same questions: ‘What was I doing before we got to the hospital?’ ‘Why am I at the hospital?’”

Advertisement

Couric was ultimately diagnosed with transient global amnesia, a sudden, temporary episode of memory loss that prevents a person from forming new memories and may also erase some recent memories, according to Mayo Clinic.

“The cause seems to be as mysterious as the brain itself.”

It is not caused by a stroke, seizure or head injury, and it usually resolves completely within 24 hours.

“[It’s] just a very weird neural episode that’s pretty uncommon and, at least in most cases, is a ‘one and done’ experience,” Molner said.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Advertisement

Couric said she finally began feeling “like herself” again around 9 p.m. and went to sleep at 2 a.m.

As TGA leaves a “permanent gap in memory” for the duration of the episode and for hours beforehand, Couric said that from around noon on that day until at least 7 p.m. will remain a “big, black hole.”

As TGA leaves a “permanent gap in memory” for the duration of the episode and for hours beforehand, Couric said that from around noon on that day until at least 7 p.m. will remain a “big, black hole.” (Getty Images)

Data shows that approximately three to eight people per 100,000 will have an episode of transient global amnesia, with people 50 years of age and older at higher risk.

The specific cause of TGA is not known, but some experts believe it stems from a “temporary dysfunction in the brain’s hippocampus — the area responsible for creating new memories,” Couric shared.

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“Doctors believe this is driven by brief interruptions in blood or oxygen flow, or microscopic spasm in the blood vessels.”

Episodes could potentially be triggered by intense physical exertion, emotional distress, extreme temperature changes or migraines, experts say.

CLICK HERE FOR MORE HEALTH STORIES

Approximately 15% of patients will have a recurrence 10 years later.

Advertisement

“Why did this happen to me? Was the altitude an issue? Was I dehydrated? Tired? Stressed? The literature doesn’t seem to indicate that these are contributing factors, but the cause seems to be as mysterious as the brain itself,” Couric wrote.

Anyone who experiences sudden memory loss, confusion, difficulty speaking, weakness, numbness, vision changes, severe headache or other stroke-like symptoms should seek immediate medical attention or call 911, doctors advise. (iStock)

“All I know is that those hours will be forever lost. Someone described it as my brain failing to hit the ‘record button.’”

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“While this was a freaky occurrence, it could have been much more serious. So ultimately, I’m relieved — even though several hours of a Saturday in June will always be missing for me.”

Advertisement

Anyone who experiences sudden memory loss, confusion, difficulty speaking, weakness, numbness, vision changes, severe headache or other stroke-like symptoms should seek immediate medical attention or call 911, doctors advise.

Continue Reading
Advertisement

Trending